With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.301224-40-8,(1,3-Dimesitylimidazolidin-2-ylidene)(2-isopropoxybenzylidene)ruthenium(VI) chloride,as a common compound, the synthetic route is as follows.,301224-40-8
General procedure: A mixture of fluorinated acid silver salt 6 (2.2eq.) and dichlororuthenium(IV) complex 5 (1.0eq.) was first dried under vacuum (13Pa) at room temperature for 1h. Dry dichloromethane (5mL) was added and the resulting mixture was stirred at room temperature for 3h in the dark. The solids were filtered off and washed with dry dichloromethane (2mL). Evaporation of the solvent afforded the product 7-9.
301224-40-8 (1,3-Dimesitylimidazolidin-2-ylidene)(2-isopropoxybenzylidene)ruthenium(VI) chloride 11763533, aruthenium-catalysts compound, is more and more widely used in various.
Reference£º
Article; Babun?k, Mario; ?im?nek, Ond?ej; Ho?ek, Jan; Ryba?kova, Marketa; Cva?ka, Josef; B?ezinova, Anna; Kvi?ala, Jaroslav; Journal of Fluorine Chemistry; vol. 161; (2014); p. 66 – 75;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI